Lipoproteins and the pathogenesis of atherosclerosis.
1989; Lippincott Williams & Wilkins; Volume: 80; Issue: 3 Linguagem: Inglês
10.1161/01.cir.80.3.719
ISSN1524-4539
AutoresDaniel Steinberg, T E Carew, Ceri A. Fielding, Alan M. Fogelman, Robert W. Mahley, Allan D. Sniderman, D.B. Zilversmit,
Tópico(s)Cancer, Lipids, and Metabolism
ResumoHomeCirculationVol. 80, No. 3Lipoproteins and the pathogenesis of atherosclerosis. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBLipoproteins and the pathogenesis of atherosclerosis. D Steinberg, T E Carew, C Fielding, A M Fogelman, R W Mahley, A D Sniderman and D B Zilversmit D SteinbergD Steinberg , T E CarewT E Carew , C FieldingC Fielding , A M FogelmanA M Fogelman , R W MahleyR W Mahley , A D SnidermanA D Sniderman and D B ZilversmitD B Zilversmit Originally published1 Sep 1989https://doi.org/10.1161/01.CIR.80.3.719Circulation. 1989;80:719–723 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Pedro-Botet J, Ascaso J, Blasco M, Brea Á, Díaz Á, Hernández-Mijares A, Pintó X and Millán J (2020) Triglicéridos, colesterol HDL y dislipidemia aterogénica en la guía europea para el control de las dislipidemias 2019, Clínica e Investigación en Arteriosclerosis, 10.1016/j.arteri.2019.12.003, 32:5, (209-218), Online publication date: 1-Sep-2020. Pedro-Botet J, Ascaso J, Blasco M, Brea Á, Díaz Á, Hernández-Mijares A, Pintó X and Millán J (2020) Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias, Clínica e Investigación en Arteriosclerosis (English Edition), 10.1016/j.artere.2019.12.001, 32:5, (209-218), Online publication date: 1-Sep-2020. Björnson E, Packard C, Adiels M, Andersson L, Matikainen N, Söderlund S, Kahri J, Hakkarainen A, Lundbom N, Lundbom J, Sihlbom C, Thorsell A, Zhou H, Taskinen M and Borén J (2020) Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects, Journal of Internal Medicine, 10.1111/joim.13017, 288:4, (422-438), Online publication date: 1-Oct-2020. Fruchart J, Santos R, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter P, Ceska R, Corsini A, Després J, Duriez P, Eckel R, Ezhov M, Farnier M, Ginsberg H, Hermans M, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti A, McPherson R, Nuñez-Cortes J, Nordestgaard B, Ogawa H, Packard C, Plutzky J, Ponte-Negretti C, Pradhan A, Ray K, Reiner Ž, Ridker P, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock J, Su T, Susekov A, Tartar A, Taskinen M, Tenenbaum A, Tokgözoğlu L, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts G, Yamashita S, Yokote K, Zambon A and Libby P (2019) The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential, Cardiovascular Diabetology, 10.1186/s12933-019-0864-7, 18:1, Online publication date: 1-Dec-2019. Allgrove J and Davison G (2018) Chocolate/Cocoa Polyphenols and Oxidative Stress Polyphenols: Mechanisms of Action in Human Health and Disease, 10.1016/B978-0-12-813006-3.00016-7, (207-219), . Kaniewska-Bednarczuk E, Mielcarek M, Chester A, Slominska E, Yacoub M and Smolenski R (2016) Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium, Nucleosides, Nucleotides & Nucleic Acids, 10.1080/15257770.2016.1163377, 35:10-12, (713-719), Online publication date: 1-Dec-2016. Shang D, Zhang Z, Wang Q, Ran Y, Shaw T, Van J and Peng Y (2016) Membrane skeleton orchestrates the platelet glycoprotein (GP) Ib‐IX complex clustering and signaling, IUBMB Life, 10.1002/iub.1559, 68:10, (823-829), Online publication date: 1-Oct-2016. El-Sayyad H (2015) Cholesterol overload impairing cerebellar function: The promise of natural products, Nutrition, 10.1016/j.nut.2014.10.017, 31:5, (621-630), Online publication date: 1-May-2015. Allgrove J and Davison G (2014) Dark Chocolate/Cocoa Polyphenols and Oxidative Stress Polyphenols in Human Health and Disease, 10.1016/B978-0-12-398456-2.00019-0, (241-251), . Séfora-Sousa M and De Angelis-Pereira M (2013) Mecanismos moleculares de ação anti-inflamatória e antioxidante de polifenóis de uvas e vinho tinto na aterosclerose, Revista Brasileira de Plantas Medicinais, 10.1590/S1516-05722013000400020, 15:4, (617-626), . Li H, Guo H and Li H (2013) Cholesterol loading affects osteoblastic differentiation in mouse mesenchymal stem cells, Steroids, 10.1016/j.steroids.2013.01.007, 78:4, (426-433), Online publication date: 1-Apr-2013. Morré D and Morré D (2012) Age-Related ENOX Proteins (arNOX) ECTO-NOX Proteins, 10.1007/978-1-4614-3958-5_9, (261-311), . Farid A and Horii Y (2012) Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis, Lipids in Health and Disease, 10.1186/1476-511X-11-92, 11:1, Online publication date: 1-Dec-2012. Southerland J, Moss K, Taylor G, Beck J, Pankow J, Gangula P and Offenbacher S (2012) Periodontitis and diabetes associations with measures of atherosclerosis and CHD, Atherosclerosis, 10.1016/j.atherosclerosis.2012.01.026, 222:1, (196-201), Online publication date: 1-May-2012. Hilfiker-Kleiner D, Haghikia A and Hilfiker A (2010) Peripartum Cardiomyopathy: Role of STAT-3 and Reactive Oxygen Species Studies on Cardiovascular Disorders, 10.1007/978-1-60761-600-9_16, (317-337), . Seripa D, Panza F, Franceschi M, D'Onofrio G, Solfrizzi V, Dallapiccola B and Pilotto A (2009) Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease, Ageing Research Reviews, 10.1016/j.arr.2008.12.003, 8:3, (214-236), Online publication date: 1-Jul-2009. Yoshino G, Tanaka M, Nakano S, Matsumoto T, Kojima M, Murakami E and Morita T (2009) Effect of rosuvastatin on concentrations of plasma lipids, urine and plasma oxidative stress markers, and plasma high-sensitivity C-reactive protein in hypercholesterolemic patients with and without type 2 diabetes mellitus: A 12-week, open-label, pilot study, Current Therapeutic Research, 10.1016/j.curtheres.2009.12.003, 70:6, (439-448), Online publication date: 1-Dec-2009. Milioti N, Bermudez-Fajardo A, Penichet M and Oviedo-Orta E (2008) Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis, Clinical and Developmental Immunology, 10.1155/2008/723539, 2008, (1-15), . Miller K and Ramos K (2008) Molecular Mechanisms of Environmental Atherogenesis Atherosclerosis and Oxidant Stress, 10.1007/978-0-387-72347-1_8, (159-210), . Abd-Allah G and Mariee A (2008) Nitrite-Mediated Inactivation of Human Plasma Paraoxonase-1: Possible Beneficial Effect of Aromatic Amino Acids, Applied Biochemistry and Biotechnology, 10.1007/s12010-008-8154-y, 150:3, (281-288), Online publication date: 1-Sep-2008. Jackson S, Abate W and Tonks A (2008) Lysophospholipid acyltransferases: Novel potential regulators of the inflammatory response and target for new drug discovery, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2008.04.001, 119:1, (104-114), Online publication date: 1-Jul-2008. Andrew A, Bernardo V, Warnke L, Davey J, Hampton T, Mason R, Thorpe J, Ihnat M and Hamilton J (2007) Exposure to Arsenic at Levels Found in U.S. Drinking Water Modifies Expression in the Mouse Lung, Toxicological Sciences, 10.1093/toxsci/kfm200, 100:1, (75-87), Online publication date: 1-Nov-2007., Online publication date: 1-Nov-2007. Liao W and Ning G (2006) Knockdown of apolipoprotein B, an atherogenic apolipoprotein, in HepG2 cells by lentivirus-mediated siRNA, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2006.03.164, 344:2, (478-483), Online publication date: 1-Jun-2006. Zhou H, Pandak W and Hylemon P (2017) Cellular mechanisms of lipodystrophy induction by HIV protease inhibitors, Future Lipidology, 10.2217/17460875.1.2.163, 1:2, (163-172), Online publication date: 1-Apr-2006. Li H, Wang A, Zhang R, Wei Y, Chen H, She Z, Huang Y, Liu D and Liang C (2006) A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages, Journal of Cellular Physiology, 10.1002/jcp.20665, 208:2, (307-318), Online publication date: 1-Aug-2006. Deambrosis I, Scalabrino E, Deregibus M, Camussi G and Bussolati B (2016) CD40-Dependent Activation of Phosphatidylinositol 3-Kinase/Akt Pathway Inhibits Apoptosis of Human Cultured Mesangial Cells Induced by Oxidized LDL, International Journal of Immunopathology and Pharmacology, 10.1177/039463200501800215, 18:2, (327-337), Online publication date: 1-Apr-2005. Tsang C, Auger C, Mullen W, Bornet A, Rouanet J, Crozier A and Teissedre P (2007) The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats, British Journal of Nutrition, 10.1079/BJN20051480, 94:2, (170-181), Online publication date: 1-Aug-2005. Luegmayr E, Glantschnig H, Wesolowski G, Gentile M, Fisher J, Rodan G and Reszka A (2004) Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins, Cell Death & Differentiation, 10.1038/sj.cdd.4401399, 11:S1, (S108-S118), Online publication date: 1-Jul-2004. Asatryan L, Ziouzenkova O, Duncan R and Sevanian A (2003) Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress, Blood, 10.1182/blood-2003-01-0293, 102:5, (1732-1739), Online publication date: 1-Sep-2003. Chen Q, Reis S, Kammerer C, McNamara D, Holubkov R, Sharaf B, Sopko G, Pauly D, Merz C and Kamboh M (2003) Association between the Severity of Angiographic Coronary Artery Disease and Paraoxonase Gene Polymorphisms in the National Heart, Lung, and Blood Institute–Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, The American Journal of Human Genetics, 10.1086/345312, 72:1, (13-22), Online publication date: 1-Jan-2003. Domingo P, Sambeat M, Pérez A and Ordoñez J (2003) Effect of Protease Inhibitors on Apolipoprotein B Levels and Plasma Lipid Profile in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, 10.1097/00126334-200305010-00017, 33:1, (114-116), Online publication date: 1-May-2003. Bliwise D (2002) Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?, Journal of Psychosomatic Research, 10.1016/S0022-3999(02)00436-1, 53:1, (539-546), Online publication date: 1-Jul-2002. Tuut M (2001) Smoking, Other Risk Factors and Fibrinogen Levels Evidence of Effect Modification, Annals of Epidemiology, 10.1016/S1047-2797(00)00226-X, 11:4, (232-238), Online publication date: 1-May-2001. Liang J, Distler O, Cooper D, Jamil H, Deckelbaum R, Ginsberg H and Sturley S (2001) HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia, Nature Medicine, 10.1038/nm1201-1327, 7:12, (1327-1331), Online publication date: 1-Dec-2001. Sakata N, Phillips T and Dixon J (2001) Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells, Journal of Lipid Research, 10.1016/S0022-2275(20)31523-6, 42:12, (1947-1958), Online publication date: 1-Dec-2001. Liang J, Wu X, Fisher E and Ginsberg H (2000) The Amino-terminal Domain of Apolipoprotein B Does Not Undergo Retrograde Translocation from the Endoplasmic Reticulum to the Cytosol, Journal of Biological Chemistry, 10.1074/jbc.M004646200, 275:41, (32003-32010), Online publication date: 1-Oct-2000. Hsu H and Twu Y (2000) Tumor Necrosis Factor-α-mediated Protein Kinases in Regulation of Scavenger Receptor and Foam Cell Formation on Macrophage, Journal of Biological Chemistry, 10.1074/jbc.M003464200, 275:52, (41035-41048), Online publication date: 1-Dec-2000. Vuong T, Stroes E, Willekes-Koolschijn N, Rabelink T, Koomans H and Joles J (1999) Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects, Kidney International, 10.1046/j.1523-1755.1999.0550031005.x, 55:3, (1005-1010), Online publication date: 1-Mar-1999. Wilson P (1999) Metabolic risk factors for coronary heart disease: current and future prospects, Current Opinion in Cardiology, 10.1097/00001573-199903000-00016, 14:2, (176), Online publication date: 1-Mar-1999. Miyazaki M, Sakonjo H and Takai S (2009) Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet , British Journal of Pharmacology, 10.1038/sj.bjp.0702833, 128:3, (523-529), Online publication date: 1-Oct-1999. Liang J, Wu X, Jiang H, Zhou M, Yang H, Angkeow P, Huang L, Sturley S and Ginsberg H (1998) Translocation Efficiency, Susceptibility to Proteasomal Degradation, and Lipid Responsiveness of Apolipoprotein B Are Determined by the Presence of β Sheet Domains, Journal of Biological Chemistry, 10.1074/jbc.273.52.35216, 273:52, (35216-35221), Online publication date: 1-Dec-1998. Schmidt-Trucksäss A, Grathwohl D, Schmid A, Boragk R, Upmeier C, Keul J and Huonker M (1998) Assessment of carotid wall motion and stiffness with tissue doppler imaging, Ultrasound in Medicine & Biology, 10.1016/S0301-5629(98)00023-4, 24:5, (639-646), Online publication date: 1-Jun-1998. Rao G and Parthasarathy S (1996) Antioxidants, atherosclerosis and thrombosis, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/S0952-3278(96)90011-3, 54:3, (155-166), Online publication date: 1-Mar-1996. Kehrer J and Smith C (1994) Free Radicals in Biology: Sources, Reactivities, and Roles in the Etiology of Human Diseases Natural Antioxidants in Human Health and Disease, 10.1016/B978-0-08-057168-3.50008-4, (25-62), . Du E, Kurth J, Wang S, Humiston P and Davis R (1994) Proteolysis-coupled secretion of the N terminus of apolipoprotein B. Characterization of a transient, translocation arrested intermediate., Journal of Biological Chemistry, 10.1016/S0021-9258(19)51064-X, 269:39, (24169-24176), Online publication date: 1-Sep-1994. Jenne D, Lowin B, Peitsch M, Böttcher A, Schmitz G and Tschopp J (1991) Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma, Journal of Biological Chemistry, 10.1016/S0021-9258(18)99123-4, 266:17, (11030-11036), Online publication date: 1-Jun-1991. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe K, Ostolaza H and Martín C (2020) Pathophysiology of Type 2 Diabetes Mellitus, International Journal of Molecular Sciences, 10.3390/ijms21176275, 21:17, (6275) September 1, 1989Vol 80, Issue 3 Advertisement Article InformationMetrics Copyright © 1989 by American Heart Associationhttps://doi.org/10.1161/01.CIR.80.3.719 Originally publishedSeptember 1, 1989 PDF download Advertisement
Referência(s)